Boston Scientific said a cybersecurity incident disrupted its global operations after the medical device maker detected the incident on August 25, 2026. The disruption has affected some information systems and business applications used to support operations, including the processing and shipment of customer orders. The company said it is working with third party cybersecurity specialists to investigate and contain the threat, but the full operational and financial impact remains unknown.
Boston Scientific said a cybersecurity incident has disrupted its global operations, affecting some of the information systems and business applications used to run its operations and process customer orders.
The medical device manufacturer said it identified the incident on August 25, 2026, and immediately activated its incident-response procedures. The company is working with third-party cybersecurity specialists to investigate the incident and contain the threat.
The disruption has affected access to certain information systems and applications supporting the company's operations, including systems used to process and ship customer orders. Boston Scientific said the disruption is expected to continue while recovery efforts are underway.
The company said it is working to restore affected functions and system access, although it has not yet determined how long a full recovery will take.
Boston Scientific has also cautioned that the full scope, nature and impact of the cybersecurity incident remain unknown. The company said its investigation is still ongoing and that it has not yet determined whether the incident is reasonably likely to have a material impact on its business.
The disclosure comes as cybersecurity threats continue to affect companies across the healthcare industry. Reuters reported that medical device manufacturers Abbott Laboratories, Stryker and Medtronic, along with health insurer Clover Health, drugmaker Novo Nordisk and West Pharmaceutical Services, have also recently experienced cyberattacks.
The incident also weighed on investor sentiment. Boston Scientific shares fell 3.5% in premarket trading on Wednesday following the disclosure, according to Reuters.
For Boston Scientific, the immediate concern is the potential effect of the disruption on its ability to maintain normal operations and fulfill customer orders. However, the company has not yet quantified any financial loss or determined whether the incident will have a material financial effect.
Boston Scientific said its investigation and recovery efforts remain underway as it works with cybersecurity specialists to contain the incident and restore affected systems.
Comments (0)
You must be logged in to post comments.
No comments yet. Be the first to start the conversation!